DEVELOPMENT AND CHARACTERIZATION OF PLANT OIL-BASED POTENT ANTICHOLINESTERASE MICROEMULSION CONTAINING WITHANIA SOMNIFERA EXTRACT WITH ENHANCED TRANSDERMAL DELIVERY OF PHYTOCONSTITUENTS FOR THE TREATMENT OF COGNITIVE DISORDERS

SNEH PRIYA; DIVYA JYOTHI; CYNTHIA LIZZIE LOBO

doi:10.22159/ijap.2023v15i1.46468

Authors

SNEH PRIYA Department of Pharmaceutics, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Nitte (Deemed to be) University, Deralakatte, Karnataka, India. https://orcid.org/0000-0002-4110-8726
DIVYA JYOTHI Department of Pharmaceutics, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Nitte (Deemed to be) University, Deralakatte, Karnataka, India https://orcid.org/0000-0002-8564-319X
CYNTHIA LIZZIE LOBO Department of Pharmacognosy, Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences, Nitte (Deemed to be) University, Deralakatte, Karnataka, India

DOI:

https://doi.org/10.22159/ijap.2023v15i1.46468

Keywords:

Alzheimer, Ashwagandha, Microemulsion

Abstract

Objective: This work was carried out to develop Cymbopogan Citratus (lemon grass)oil based microemulsion formulation loaded with the extract of Withania somnifera which possess enhanced transdermal delivery of phytoconstituents with anticholinesterase activity useful in treating Alzheimer’s disease.

Methods: Methanolic extract of Withania somnifera roots were prepared and it was investigated for the inhibition of acetylcholinesterase (AChE) activity by Ellman’s assay. Based on the acetylcholinesterase activity, the specific amount of extract was loaded on to the microemulsion formulation. The Cymbopogan Citratus oil, tween 20, ethanol was used as oil phase, surfactant, and cosurfactant, respectively, for the preparation of microemulsion. Pseudo ternary phase diagram was constructed using a water titration method. The microemulsion formulations were characterized for droplet size, PDI, zeta potential and drug content. The optimized formulation was subjected to in vitro drug release and permeation studies and compared with the extract.

Results: IC₅₀ value of ashwagandha extract for anticholinesterase activity was found to be 68.73 µg/ml. The optimized microemulsion formulation had droplet size of 199.9±0.3 nm with PDI 0.029±0.2, zeta potential of-19.49±0.7mv and drug content was found to be 97.5±1.3%. The optimized microemulsion formulation showed 85±1.02% release of withaferin A after 24 h of in vitro drug release study. The prepared microemulsion loaded with ashwagandha extract showed excellent permeation of withaferin A(1.4µg/cm²/min) than the flux obtained from extract solution (0.7µg/cm²/min).

Conclusion: Optimised microemulsion formulation is suitable for transdermal delivery of anticholinesterase phytoconstituents from ashwagandha extract hence useful in the treatment of Alzheimer’s disease

Downloads

Download data is not yet available.

References

George A. A role for the regulation of the melatonergic pathways in Alzheimer’s disease and other neurodegenerative and psychiatric conditions. In: Gokhare AR, Akula R, editors. Seratonin and melatonin: their functional role in plants, food, phytomedicine, and human health. New York: Taylor & Francis Group; 2016.

Potyk D. Treatments for Alzheimer disease. South Med J. 2005;98(6):628-35. doi: 10.1097/01.SMJ.0000166671. 86815.C1, PMID 16004170.

Inglis F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl. 2002;1(127):45-63. PMID 12139367.

Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. NeuroReport. 2002;13(14):1715-20. doi: 10.1097/00001756-200210070-00005, PMID 12395110.

Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. 1997;30(2):181-90. doi: 10.1016/s0197-0186(96)00025-3, PMID 9017665.

Ingkaninan K, Changwijit K, Suwanborirux K. Vobasinyl-iboga bisindole alkaloids, potent acetylcholinesterase inhibitors from Tabernaemontana divaricata root. J Pharm Pharmacol. 2006;58(6):847-52. doi: 10.1211/jpp.58.6.0015, PMID 16734986.

Choudhary MI, Yousuf S, Nawaz SA, Ahmed S, Atta-ur-Rahman. Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo). 2004;52(11):1358-61. doi: 10.1248/cpb.52.1358, PMID 15520512.

Winblad B, Machado JC. Use of rivastigmine transdermal patch in the treatment of Alzheimer’s disease. Expert Opin Drug Deliv. 2008;5(12):1377-86. doi: 10.1517/ 17425240802542690, PMID 19040398.

Utsuki T, Uchimura N, Irikura M, Moriuchi H, Holloway HW, Yu QS. Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy. J Pharmacol Exp Ther. 2007;321(1):353-61. doi: 10.1124/jpet.106.118000, PMID 17255466.

El Maghraby GM. Transdermal delivery of hydrocortisone from eucalyptus oil microemulsion: effects of cosurfactants. Int J Pharm. 2008;355(1-2):285-92. doi: 10.1016/j.ijpharm.2007.12.022, PMID 18243604.

Sebastian G, Priya S, P James J, MM A, Sannidhi, Prabhu VK. Computational tools assisted formulation optimization of nebivolol hydrochloride-loaded PLGA nanoparticles by 32 factorial designs. Int J App Pharm. 2022;14(4):251-8. doi: 10.22159/ijap.2022v14i4.44865.

Jyothi D, Cheriyan SP, Ahmed SRR, Priya S, James JP, P TG. Microwave assisted green synthesis of silver nanoparticles using coleus amboinicus leaf extract. Int J App Pharm. 2020;12(3):56-61. doi: 10.22159/ijap.2020v12i3.37121.

James JP, Jyothi D, Priya S. In silico screening of phytoconstituents with antiviral activities against SARS-COV-2 main protease, Nsp12 polymerase, and Nsp13 helicase proteins. Lett Drug Des Discov. 2021 Aug 1;18(8):841-57. doi: 10.2174/1570180818666210317162502.

James JP, Sasidharan P, Mandal SP, Dixit SR. Virtual screening of alkaloids and flavonoids as acetylcholinesterase and MAO-B inhibitors by molecular docking and dynamic simulation studies. Polycyclic Aromat Compd. 2022 Aug 1:1-25. doi: 10.1080/10406638.2022.2102662.

Mathew M, Subramanian S. In vitro screening for anti-cholinesterase and antioxidant activity of methanolic extracts of ayurvedic medicinal plants used for cognitive disorders. Plos One. 2014 Jan 23;9(1):e86804. doi: 10.1371/ journal.pone.0086804, PMID 24466247.

Gurav N, Solanki B, Gadhvi I, Patel P, Sen D. RP-HPLC method development and validation for estimation of withaferin-A in ranger capsule. Int J Pharm Sci Res. 2015;6(12):5141-6.

Myers D. Solubilization, micellar catalysis, and microemulsions. Surfaces, interfaces, and colloids: principles and applications. 2nd ed. New York: John Wiley & Sons; 1999. p. 397-414.

Yuan Y, Li SM, Mo FK, Zhong DF. Investigation of microemulsion system for transdermal delivery of meloxicam. Int J Pharm. 2006;321(1-2):117-23. doi: 10.1016/j.ijpharm.2006.06.021, PMID 16876972.

Kogan A, Shalev DE, Raviv U, Aserin A, Garti N. Formation and characterization of ordered bicontinuous microemulsions. J Phys Chem B. 2009;113(31):10669-78. doi: 10.1021/jp901617g, PMID 19719271.

Adams M, Gmünder F, Hamburger M. Plants traditionally used in age related brain disorders-a survey of ethnobotanical literature. J Ethnopharmacol. 2007;113(3):363-81. doi: 10.1016/j.jep.2007.07.016, PMID 17720341.

Shi J, Cong W, Wang Y, Liu Q, Luo G. Microemulsion-based patch for transdermal delivery of huperzine a and ligustrazine phosphate in the treatment of Alzheimer’s disease. Drug Dev Ind Pharm. 2012;38(6):752-61. doi: 10.3109/03639045.2011.625031, PMID 22014311.

Ellman GL, Courtney KD, Andres Jr V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology. 1961;7(2):88-95. doi: 10.1016/0006-2952(61)90145-9.

Schwarz JS, Weisspapir MR, Friedman DI. Enhanced transdermal delivery of diazepam by submicron emulsion (SME) creams. Pharm Res. 1995;12(5):687-92. doi: 10.1023/a:1016255408348, PMID 7479554.

Flaten GE, Palac Z, Engesland A, Filipovic Grcic J, Vanic Z, Skalko Basnet N. In vitro skin models as a tool in optimization of drug formulation. Eur J Pharm Sci. 2015;75:10-24. doi: 10.1016/j.ejps.2015.02.018, PMID 25746955.

Yaghmur A, Aserin A, Garti N. Phase behavior of microemulsions based on food-grade nonionic surfactants: effect of polyols and short-chain alcohols. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2002;209(1):71-81. doi: 10.1016/S0927-7757(02)00168-1.

Megrab NA, Williams AC, Barry BW. Oestradiol permeation across human skin, Silastic and snakeskin membranes: the effects of ethanol/water co-solvent systems. International Journal of Pharmaceutics. 1995;116(1):101-12. doi: 10.1016/0378-5173(94)00321-U.

Williams AC, Barry BW. Terpenes and the lipid-protein–partitioning theory of skin penetration enhancement. Pharm Res. 1991;8(1):17-24. doi: 10.1023/a:1015813803205, PMID 2014203.

Shah HS, Nasrullah U, Zaib S, Usman F, Khan A, Gohar UF. Preparation, characterization, and pharmacological investigation of withaferin-a loaded nanosponges for cancer therapy; in vitro, in vivo and molecular docking studies. Molecules. 2021;26(22):6990. doi: 10.3390/molecules26226990, PMID 34834081.

Haroon Khan. Cholinesterase and lipoxygenase inhibition of whole plant Withania somnifera. Afr J Pharm Pharmacol. 2011;5(20):2272-5. doi: 10.5897/AJPP11.575.

Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in caco-2 cell monolayers. Eur J Pharm Sci. 2002;16(4-5):237-46. doi: 10.1016/s0928-0987(02)00055-6, PMID 12208453.

Tashtoush BM, Bennamani AN, AL-Taani BM. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery. Pharm Dev Technol. 2013;18(4):834-43. doi: 10.3109/10837450.2012.727003, PMID 23030413.